Coloretti, I.; Tosi, M.; Biagioni, E.; Morselli, F.; Munari, E.; Bertolini, J.; Ferrari, S.; Meschiari, M.; Franceschini, E.; Nielsen, N.D.;
et al. Acquisition Origin Matters: Clinical, Microbiological and Immunological Characteristics and Treatment Effects in Community- vs. Hospital-Acquired Septic Shock. Antibiotics 2026, 15, 169.
https://doi.org/10.3390/antibiotics15020169
AMA Style
Coloretti I, Tosi M, Biagioni E, Morselli F, Munari E, Bertolini J, Ferrari S, Meschiari M, Franceschini E, Nielsen ND,
et al. Acquisition Origin Matters: Clinical, Microbiological and Immunological Characteristics and Treatment Effects in Community- vs. Hospital-Acquired Septic Shock. Antibiotics. 2026; 15(2):169.
https://doi.org/10.3390/antibiotics15020169
Chicago/Turabian Style
Coloretti, Irene, Martina Tosi, Emanuela Biagioni, Federica Morselli, Elena Munari, Jacopo Bertolini, Sara Ferrari, Marianna Meschiari, Erica Franceschini, Nathan D. Nielsen,
and et al. 2026. "Acquisition Origin Matters: Clinical, Microbiological and Immunological Characteristics and Treatment Effects in Community- vs. Hospital-Acquired Septic Shock" Antibiotics 15, no. 2: 169.
https://doi.org/10.3390/antibiotics15020169
APA Style
Coloretti, I., Tosi, M., Biagioni, E., Morselli, F., Munari, E., Bertolini, J., Ferrari, S., Meschiari, M., Franceschini, E., Nielsen, N. D., Busani, S., & Girardis, M.
(2026). Acquisition Origin Matters: Clinical, Microbiological and Immunological Characteristics and Treatment Effects in Community- vs. Hospital-Acquired Septic Shock. Antibiotics, 15(2), 169.
https://doi.org/10.3390/antibiotics15020169
